Search results
Gelclair® is a viscous gel specially formulated to aid in the painful symptoms of mucositis of the oropharyngeal cavity. It forms a protective film that, by adhering to the mucosa of the oropharyngeal cavity, can prevent further irritations thus contributing to the rapid relief of pain.
Patient-controlled analgesia with morphine is recommended as the treatment of choice for oral mucositis pain in patients undergoing HSCT [I, A]. Regular oral pain assessment using validated instruments for self-reporting is essential.
1 paź 2011 · Gelclair is an oral lubricating gel used in the management of oral mucositis (OM). We evaluated its efficacy, tolerance and impact on oral cavity microbial colonization in patients with OM after allogeneic hematopoietic stem cells transplantation. Material/Method. Gelclair was administered in a group of 22 patients with active OM.
The clinical effectiveness of Gelclair in the management of oral mucositis. Aust Nurs J. 2009 Apr;16 (9):30-3. PMID: 19437954.
28 lip 2020 · The updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting-specific, evidence-based tool to help with the management of mucositis in patients who have cancer.
10 sty 2023 · Oral mucositis (OM) is a debilitating condition that affects patients undergoing cancer chemotherapy and/or radiotherapy to the head and neck region. OM is characterized by inflammation and ulceration of the oral mucosa, oral erythema, and pain.
Low-level laser therapy (wavelength at 650 nm, power of 40 mW, and each square cm treated with the required time to a tissue energy dose of 2 J/cm2), be used to prevent oral mucositis in patients receiving HSCT conditioned with high-dose chemotherapy, with or without total body irradiation.
